Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Speculation on the supplemental amendment to 148

so it would appear to me that this language could could present huge prior art hurdles.

Makes you wonder why they amended the claim in the first place

Share
New Message
Please login to post a reply